← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Virion Systems, Inc.
Rockville, MD
$7,564,670
Total funding
10
Grants
Funding over time
peak $2.1M · FY2005–10$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$7,564,670 · 10
By mechanism
R01$3,841,566 · 2
R24$1,495,363 · 1
R44$829,309 · 1
R43$638,795 · 3
R41$517,005 · 2
R29$242,632 · 1
Investigators at Virion Systems, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Accelerated Viral Inhibition Assay$813,763
R01 · FY2006 · AI
IMPROVEMENT OF THE COTTON RAT MODEL OF HUMAN DISEASES$717,767
R24 · FY2001 · RR
The Role of TLR4 and RSV F Protein in Immunity to RSV$495,850
R01 · FY2008 · AI
The Role of TLR4 and RSV F Protein in Immunity to RSV$490,735
R01 · FY2007 · AI
The Role of TLR4 and RSV F Protein in Immunity to RSV$490,668
R01 · FY2006 · AI
IMPROVEMENT OF THE COTTON RAT MODEL OF HUMAN DISEASES$486,173
R24 · FY2002 · RR
The role of TLR4 and RSV F protein in immunity to RSV$474,338
R01 · FY2009 · AI
The Role of TLR4 and RSV F Protein in Immunity to RSV$473,632
R01 · FY2005 · AI
The Role of TLR4 and RSV F Protein in Immunity to RSV$473,632
R01 · FY2004 · AI
Treatment of RSV Bronchiolitis with NSAIDs$438,794
R43 · FY2006 · AI
Establishment fo HIV infection in cotton rats$424,749
R44 · FY2008 · AI
Establishment fo HIV infection in cotton rats$404,560
R44 · FY2007 · AI
Novel Model to Predict Safety and Efficacy of Microbicides$336,245
R41 · FY2006 · AI
IMPROVEMENT OF THE COTTON RAT MODEL OF HUMAN DISEASES$291,423
R24 · FY2000 · RR
Novel Model to Predict Safety and Efficacy of Microbicides$158,776
R41 · FY2007 · AI
The role of TLR4 and RSV F protein in immunity to RSV$128,948
R01 · FY2010 · AI
INITIATION OF VIRUS SPECIFIC CD8+ T CELL RESPONSES$105,000
R29 · FY2001 · AI
INITIATION OF VIRUS SPECIFIC CD8+ T CELL RESPONSES$105,000
R29 · FY2002 · AI
Mucosal RSV vaccine using CpG oligodeoxynucleotides$100,001
R43 · FY2003 · AI
Establishment of HIV Infection in cotton rats$100,000
R43 · FY2003 · AI